维普期刊资源整合服务平台（V6.5）

22篇 您的检索式：作者名="Zimbroff"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Zip 80 mg/d and 160 mg/d in the acute exacerbation of schizophrenia and schizoaffective disorder:A6 week placebo controlled trial zip study group显示文摘	Daniel DG zimbroff DL potkin SG	1999	Neuropsychopharmacology1999，20，5：	1
2	Zip 80mg/d and 160mg/d in the acute Exacerbation of schizophrenia and schizoaffective disorder: A 6 week placebo controlled trial zip study gmup显示文摘	Daniel D G zimbroff D L potkin S G	1999	Neuropsychopharma- cology1999，20，5：	1
3	Zip 80mg/d and 160mg/d in the acute exacerbation of schizophrenia and schizoaffective disorder: A 6 week placebo controlled trial zip study group 显示文摘	Daniel DG Zimbroff DL Potkin SG	1999	Neuropsychophar macology1999，20，5：	1
4	Controlled,doseresponse study of sertindole arid haloperidol in the treatment of schizophrenia显示文摘	Zimbroff D L Kane J M Jamminga C A	1997	Am J Psychiatry1997，154，：	1
5	Controlled,dose - response study of sertindole and haloperidol in the treatment of schizophrenia显示文摘	Zimbroff DL Kane JM Tamminga CA	1997	Am J Psychiatry1997，154，：	1
6	Bset clinical practice with ziprasidone IM:update after 2 years of experience显示文摘	ZIMBROFF DL ALLEN MH BATTAGLIA J	2005	CNS Spectr2005，10，9：	1
7	Zip 80mg/d and 160mg/d in the acute exacerbation of schizophrenia and sehizoaffective disorder: A 6 week placebo controlled trial zip study group显示文摘	Daniel DG zimbroff DL potkin SG	1999	Neuropsychop]larn/a- cology1999，20，5：	1
8	The tolera- bility of intramuscular ziprasidone and haloperidol treatment and the transition to oral therapy 显示文摘	Daniel DG Zimbroff DL Swift RH	2004	Int Clin Psychophar- macol2004，19，1：	1
9	Bases clinical practice with ziprasidone IM:update after 2 years of experience显示文摘	ALLEN MH BATTAGLIA J	2005	CNS Sperctr2005，10，9：	1
10	Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder:a 6-week placebo-controlled trial显示文摘	Daniel DG Zimbroff Dl Potkin SG	1999	Neuropsychopharmacology1999，20，：	1
11	The tolerability of intramuscular ziprasidone and haloperidol treatment and the transition to oral therapy显示文摘	Daniel DG Zimbroff DL Swift RH		0，，：	1
12	Pharmacological control of acute agitation:Focus on intra-muscular preparations显示文摘	Zimbroff DL		0，，：	1
13	Pharmacological control of acute agitation: focus on intramuscular preparations 显示文摘	Zimbroff DL	2008	CNS Drugs2008，22，3：	1
14	The tolerability of intramuscular ziprasidone and haloperidol treatment and the transition to oral therapy显示文摘	Daniel D G Zimbroff D L Swift R H	2004	Int-Clin-Psychopharmacol2004，19，1：	1
15	Controlled,dose-response study of sertindole and haloperidol in the treatment of schizophrenia显示文摘	Kane JM Tamminga CA	1997	Am J Psychi atry1997，154，：	1
16	Best clinical practice with ziprasidone IM:update after 2 years of experience显示文摘	Zimbroff Dl Allen MH Battaglia J	2005	CNS Spectr2005，10，9：	1
17	Ziprasidone 80mg/day and 160mg/day in the acute exacerbation of schizophrenia Ziprasidone Study Group显示文摘	DANIEL DG ZIMBROFF DL POTKIN SG	1999	Neuropsychopharmacol1999，20，5：	1
18	Best clinical practice with ziprasidone IM:update after 2 years of experience显示文摘	Zimbroff DL Allen MH	2005	CNS Spectr2005，10，：	1
19	Comparison of ziprasi-done and aripiprazole in acutely ill patients with schizophrenia orschizoaffective disorder: a randomized, double-blind ,4-week study显示文摘	Zimbroff D Warrington L Lpebel A	2007	Int Clin Psychopharmacol2007，22，：	1
20	Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebocontrolled trail显示文摘	DANIEL D G ZIMBROFF D L POTKIN S G	1999	Neuropsychopharmacology1999，20，5：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示